Biopharmaceutical Product Attributes and Biological Consequences Community

 View Only
Back to discussions
Expand all | Collapse all

Open Scientific Discussion - Biological Consequences of Airway Delivery of Therapeutic Antibodies for Respiratory Infections

  • 1.  Open Scientific Discussion - Biological Consequences of Airway Delivery of Therapeutic Antibodies for Respiratory Infections

    Community Leadership
    Posted 07-14-2025 10:37
      |   view attached

    Hello BPABC Community, 

    The BPABC and Inhalation and Nasal Community (INC) are co-hosting an OSD on biological consequences following inhalation delivery of therapeutic antibodies by Dr. Thomas Secher, a Senior Researcher at INSERM, France (see attached flyer for details). 

    Please join a discussion on this exciting topic on 23 July 2025 from Noon to 1 PM (US EDT) and 6-7 PM (CEST) using the Teams information below:

    Join the meeting now

    Meeting ID: 294 700 943 318 7

    Passcode: 5hB7bv7Y

    Hope to see you all there. 

    Warm regards, 

    BPABC Community Leadership



    ------------------------------
    Mayank Patel Ph.D.
    Senior Director
    AstraZeneca
    Gaithersburg MD
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------

    Attachment(s)

    pdf
    Secher flyer.pdf   1012 KB 1 version